Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 1
2015 2
2016 2
2018 3
2019 1
2020 3
2021 8
2022 6
2023 8
2024 5
2025 3
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

38 results

Results by year

Filters applied: . Clear all
Page 1
Osteosarcoma of the Diaphysis: A Report from the Cooperative Osteosarcoma Study Group (COSS).
Bielack SS, Blattmann C, Kager L, Baumhoer D, Borkhardt A, Feuchtinger T, Friedel G, Hardes J, Harrabi SB, Hassenpflug W, VON Kalle T, Kevric M, Knoll A, Kühne T, Rossig C, Sorg B, Werner M, Windhager R, Hecker-Nolting S. Bielack SS, et al. Among authors: hecker nolting s. Anticancer Res. 2025 Nov;45(11):5031-5043. doi: 10.21873/anticanres.17844. Anticancer Res. 2025. PMID: 41151898
Teleangiectatic Osteosarcoma Treated by Surgery and Chemotherapy: A Report of 223 Affected Patients From the Cooperative Osteosarcoma Study Group (COSS).
Bielack SS, Mettmann V, Baumhoer D, Beilken A, Blattmann C, Friedel G, Hardes J, Hassenpflug W, Kager L, Kevric M, von Kalle T, Kulozik A, Metzler M, Nathrath M, Rossig C, Sorg B, Werner M, Hecker-Nolting S. Bielack SS, et al. Among authors: hecker nolting s. Cancer Med. 2025 Sep;14(17):e71211. doi: 10.1002/cam4.71211. Cancer Med. 2025. PMID: 40923337 Free PMC article.
Prognostic factors in patients with relapsed high-grade osteosarcoma: a systematic review.
Rubio-San-Simón A, Wilson W, Sironi G, le Deley MC, Palmerini E, Gaspar N, Piperno-Neumann S, Hecker-Nolting S, Strauss S, van Ewijk R, Meazza C; FOSTER Consortium (Fight OsteoSarcoma Through European Research), work package 3 on recurrent/refractory osteosarcoma trials. Rubio-San-Simón A, et al. Among authors: hecker nolting s. Br J Cancer. 2025 Oct;133(7):1020-1028. doi: 10.1038/s41416-025-03118-x. Epub 2025 Jul 29. Br J Cancer. 2025. PMID: 40731087
Osteosarcoma as a secondary malignancy following rhabdomyosarcoma: A report of 28 affected patients from the Cooperative Osteosarcoma Study Group (COSS).
Bielack SS, Mettmann V, Hecker-Nolting S, Borkhardt A, Hardes J, Kager L, von Kalle T, Kevric M, Koscielniak E, Kratz CP, Kühne T, Nathrath M, Rossig C, Sorg B, Sparber-Sauer M, Werner M, Blattmann C. Bielack SS, et al. Among authors: hecker nolting s. Pediatr Blood Cancer. 2024 Dec;71(12):e31344. doi: 10.1002/pbc.31344. Epub 2024 Sep 29. Pediatr Blood Cancer. 2024. PMID: 39344062
Biological Sample Collection to Advance Research and Treatment: A Fight Osteosarcoma Through European Research and Euro Ewing Consortium Statement.
Green D, van Ewijk R, Tirtei E, Andreou D, Baecklund F, Baumhoer D, Bielack SS, Botchu R, Boye K, Brennan B, Capra M, Cottone L, Dirksen U, Fagioli F, Fernandez N, Flanagan AM, Gambarotti M, Gaspar N, Gelderblom H, Gerrand C, Gomez-Mascard A, Hardes J, Hecker-Nolting S, Kabickova E, Kager L, Kanerva J, Kester LA, Kuijjer ML, Laurence V, Lervat C, Marchais A, Marec-Berard P, Mendes C, Merks JHM, Ory B, Palmerini E, Pantziarka P, Papakonstantinou E, Piperno-Neumann S, Raciborska A, Roundhill EA, Rutkauskaite V, Safwat A, Scotlandi K, Staals EL, Strauss SJ, Surdez D, Sys GML, Tabone MD, Toulmonde M, Valverde C, van de Sande MAJ, Wörtler K, Campbell-Hewson Q, McCabe MG, Nathrath M. Green D, et al. Among authors: hecker nolting s. Clin Cancer Res. 2024 Aug 15;30(16):3395-3406. doi: 10.1158/1078-0432.CCR-24-0101. Clin Cancer Res. 2024. PMID: 38869831 Free PMC article.
Osteosarcoma Arising as a Secondary Malignancy following Treatment for Hematologic Cancer: A Report of 33 Affected Patients from the Cooperative Osteosarcoma Study Group (COSS).
Bielack SS, Mettmann V, Baumhoer D, Blattmann C, Burkhardt B, Deinzer CKW, Kager L, Kevric M, Mauz-Körholz C, Müller-Abt P, Reinhardt D, Sabo AA, Schrappe M, Sorg B, Windhager R, Hecker-Nolting S. Bielack SS, et al. Among authors: hecker nolting s. Cancers (Basel). 2024 May 11;16(10):1836. doi: 10.3390/cancers16101836. Cancers (Basel). 2024. PMID: 38791915 Free PMC article.
Primary Multi-Systemic Metastases in Osteosarcoma: Presentation, Treatment, and Survival of 83 Patients of the Cooperative Osteosarcoma Study Group.
Mettmann VL, Blattmann C, Friedel G, Harrabi S, von Kalle T, Kager L, Kevric M, Kühne T, Nathrath M, Sorg B, Werner M, Bielack SS, Hecker-Nolting S. Mettmann VL, et al. Among authors: hecker nolting s. Cancers (Basel). 2024 Jan 8;16(2):275. doi: 10.3390/cancers16020275. Cancers (Basel). 2024. PMID: 38254767 Free PMC article.
A systematic review of recent phase-II trials in refractory or recurrent osteosarcoma: Can we inform future trial design?
van Ewijk R, Cleirec M, Herold N, le Deley MC, van Eijkelenburg N, Boudou-Rouquette P, Risbourg S, Strauss SJ, Palmerini E, Boye K, Kager L, Hecker-Nolting S, Marchais A, Gaspar N; FOSTER Consortium (Fight OsteoSarcoma Through European Research), work package 3 on recurrent/refractory osteosarcoma trials. van Ewijk R, et al. Among authors: hecker nolting s. Cancer Treat Rev. 2023 Nov;120:102625. doi: 10.1016/j.ctrv.2023.102625. Epub 2023 Sep 15. Cancer Treat Rev. 2023. PMID: 37738712 Free article. Review.
38 results